EMR vs REPL · P/E 34, rev $4.86B vs $825.7M cap
Emerson Electric Company (EMR) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
REPL does not have a complete income-statement cache yet.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. REPL currently screens at market cap $825.7M.
Not investment advice. Open the EMR and REPL stock pages for the full models.
Not investment advice.